Bing-Jun Dong

Bing-Jun Dong


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
WZWan-Ying Zhang
Wan-Ying Zhang
XZXiao-Li Zheng
Xiao-Li Zheng
PCPaolo Saul Coghi
Paolo Saul Coghi
JCJun-Hui Chen
Jun-Hui Chen
BDBing-Jun Dong
Bing-Jun Dong
Xing-Xing FanXing-Xing Fan
Xing-Xing Fan
With the COVID-19 pandemic, the importance of vaccines has been widely recognized and has led to increased research and development efforts. Vaccines also play a crucial role in cancer treatment by activating the immune system to target and destroy cancer cells. However, enhancing the efficacy of cancer vaccines remains a challenge. Adjuvants, which enhance the immune response to antigens and improve vaccine effectiveness, have faced limitations in recent years, resulting in few novel adjuvants being identified. The advancement of artificial intelligence (AI) technology in drug development has provided a foundation for adjuvant screening and application, leading to a diversification of adjuvants. This article reviews the significant role of tumor vaccines in basic research and clinical treatment and explores the use of AI technology to screen novel adjuvants from databases. The findings of this review offer valuable insights for the development of new adjuvants for next-generation vaccines.